FDA Clears Roche’s CSF Biomarkers for Alzheimer’s Disease

biomarker for alzheimers disease

Roche has obtained FDA clearance for Alzheimer’s tests in the U.S. that include two ratios comprising three assays. The Elecsys® beta-Amyloid (1-42)(Abeta42) protein , Elecsys® Phospho-Tau (181P) CSF , total-Tau CSF (tTau)can aid in the diagnosis of Alzheimer’s disease by measuring levels of beta-amyloid and tau protein. The Abeta42 and pTau181 assays are currently available, while the total … Read more